- 2.2Impact Factor
- 3.5CiteScore
- 27 daysTime to First Decision
Tomography, Volume 8, Issue 5
October 2022 - 43 articles
Cover Story: Malignant Pleural Mesothelioma (MPM) is an aggressive type of cancer that develops from mesothelial cells lining the pleura. Exposure to asbestos fibers from industrial and environmental sources is the main cause of MPM. A combination of surgery and chemotherapy is currently the most effective treatment available for MPM, but they are extremely aggressive and cause significant collateral damage to the body. They also lack the ability to eliminate residual microscopic disease, which can lead to the recurrence of the tumor. As a result, the prognosis of MPM is very poor, with a median survival of 9–12 months. Here, we investigated two alternative treatments in an in vivo porcine model of mesothelioma, Radiofrequency Ablation, a minimally invasive tumor treatment, and MRI-guided Focused Ultrasound Surgery, a completely noninvasive tumor treatment. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.

